Imunon, Inc. Increase (Decrease) in Other Operating Assets
Imunon, Inc. (IMNN) reported Increase (Decrease) in Other Operating Assets of $241.51 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2024-03-28
- Imunon, Inc. increase (decrease) in other operating assets for the quarter ending 2018-03-31 was -$270.19K.
- Imunon, Inc. increase (decrease) in other operating assets for the quarter ending 2017-12-31 was -$20.47K, a 101.59% decline year-over-year.
- Imunon, Inc. increase (decrease) in other operating assets for the quarter ending 2017-09-30 was $1.25M.
- Imunon, Inc. increase (decrease) in other operating assets for the quarter ending 2017-06-30 was -$292.23K, a 171.50% decline year-over-year.
- Imunon, Inc. increase (decrease) in other operating assets for fiscal 2022 was $241.51K, a 93.63% increase from fiscal 2021.
- Imunon, Inc. increase (decrease) in other operating assets for fiscal 2021 was $124.73K.
- Imunon, Inc. increase (decrease) in other operating assets for fiscal 2017 was $649.70K, a 11.39% decline from fiscal 2016.
- Imunon, Inc. increase (decrease) in other operating assets for fiscal 2016 was $733.19K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $241.51K 10-K · filed 2024-03-28 | -$133.49K 10-K · filed 2023-03-30 | |||
| 2021-12-31 | $124.73K 10-K · filed 2023-03-30 | ||||
| 2018-03-31 | -$270.19K 10-Q · filed 2018-05-11 | -$290.67K derived: sum of 2 quarters · filed 2018-05-11 | $955.49K derived: sum of 3 quarters · filed 2018-05-11 | $663.26K derived: sum of 4 quarters · filed 2018-05-11 | |
| 2017-12-31 | -$20.47K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | $1.23M derived: sum of 2 quarters · filed 2018-03-27 | $933.45K derived: sum of 3 quarters · filed 2018-03-27 | $649.70K 10-K · filed 2018-03-27 | |
| 2017-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $953.92K derived: sum of 2 quarters · filed 2017-11-14 | $670.17K 10-Q · filed 2017-11-14 | $1.96M derived: sum of 4 quarters · filed 2018-05-11 | |
| 2017-06-30 | -$292.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$575.98K 10-Q · filed 2017-08-14 | $713.59K derived: sum of 3 quarters · filed 2018-05-11 | $51.18K derived: sum of 4 quarters · filed 2018-05-11 | |
| 2017-03-31 | -$283.75K 10-Q · filed 2018-05-11 | $1.01M derived: sum of 2 quarters · filed 2018-05-11 | $343.41K derived: sum of 3 quarters · filed 2018-05-11 | $752.09K derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | $627.16K derived: sum of 2 quarters · filed 2018-03-27 | $1.04M derived: sum of 3 quarters · filed 2018-03-27 | $733.19K 10-K · filed 2018-03-27 | |
| 2016-09-30 | -$662.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$253.73K derived: sum of 2 quarters · filed 2017-11-14 | -$556.38K 10-Q · filed 2017-11-14 | -$855.51K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | $408.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $106.03K 10-Q · filed 2017-08-14 | -$193.10K derived: sum of 3 quarters · filed 2017-08-14 | $89.85K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | -$302.66K 10-Q · filed 2017-05-12 | -$601.78K derived: sum of 2 quarters · filed 2017-05-12 | -$318.83K derived: sum of 3 quarters · filed 2017-05-12 | -$388.22K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | -$299.12K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | -$16.17K derived: sum of 2 quarters · filed 2017-03-24 | -$85.57K derived: sum of 3 quarters · filed 2017-03-24 | -$257.70K 10-K · filed 2017-03-24 | |
| 2015-09-30 | $282.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $213.56K derived: sum of 2 quarters · filed 2016-11-10 | $41.42K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$69.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$241.53K 10-Q · filed 2016-08-15 | |||
| 2015-03-31 | -$172.14K 10-Q · filed 2016-05-16 | ||||
| 2014-12-31 | $213.95K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |